Delisting Determination, The Nasdaq Stock Market, LLC,
November 8, 2019, DermTech, Inc. The Nasdaq
Stock Market, Inc. (the Exchange) has determined to remove
from listing the warrant of DermTech, Inc.
(the Company), effective at the opening of the trading
session on November 18, 2019. Based on review of information
provided by the Company, Nasdaq Staff determined that the
Company no longer qualified for listing on the Exchange
pursuant to Listing Rule 5550(a)(3). The Company was notified
of the Staffs determination on August 22, 2019.
The Company appealed the determinations to a Hearing Panel.
On September 3, 2019, the Company was notified that
it had not complied with the requirements of IM-5101-22, which
served as an additional basis for delisting.
Upon review of the information provided
by the Company, the Panel issued a decision dated
October 16, 2019, declaring that the Company meets the criteria
for initial listings on the Exchange, and will, accordingly, continue
the Company listing on the Capital Market of the common stock. The
Panel further decided to delist the Company warrant, effective
at the open of trading on October 18, 2019.
The Company did not request a review of the Panels decision
by the Nasdaq Listing and Hearing Review Council. The
Listing Council did not call the matter for review.
The Panels Determination to delist the Company
became final on October 18, 2019.